NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
29/11/2025 08:28
NASDAQ TRADE HALT CONTINUES MBRX.O HALT NEWS PENDING AT 03:28 AM
Recent news on Moleculin Biotech
See all newsMoleculin Biotech Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Moleculin Secures Australian Patent For Annamycin Formulation Technology
Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
Brief: Moleculin Biotech Completes Dosing In Part A Of Miracle Trial Data Readout On Track For Q1 2027
NASDAQ RESUMED AT 09:00 AM